International Clinical Trial: Vonoprazan-based Versus Esomeprazole-based Triple Therapy for Helicobacter Pylori Eradication

Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07537634) titled 'Vonoprazan-based Versus Esomeprazole-based Triple Therapy for Helicobacter Pylori Eradication' on April 9.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

Condition: Helicobacter Pylori Infection Dyspepsia Peptic Ulcer Disease

Intervention: Drug: vonoprazan-based triple therapy (VAL regimen)

Recruitment Status: Not recruiting

Phase: Phase 4

Date of First Enrollment: April 15, 2026

Target Sample Size: 80

Countri...